Upgrade to SI Premium - Free Trial

Canaccord Reiterates Hold Rating on Amgen (AMGN)

September 23, 2026 6:38 AM
Canaccord analyst Gary Nachman reiterated a Hold rating and $384.00 price target on Amgen (NASDAQ: AMGN).The analyst commented: "AMGN announced ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments